Taking the big leapfrog to advance T2D care

01 Dec 2021
Taking the big leapfrog to advance T2D care
During the Guardians for Health Summit 2021 supported by Boehringer Ingelheim, several distinguished speakers shared their insights into the importance of type 2 diabetes (T2D) guideline adherence and patient empowerment, as well as the impact of clinical inertia on the burden of cardiorenal metabolic diseases.
Editor's Recommendations